ArticleNucleic acids research2026
DeepECC: a deep learning framework for genome-wide identification and analysis of human cancer eccDNAs.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Extrachromosomal circular DNAs (eccDNAs) are closed circular DNA molecules widespread across eukaryotic cells, with emerging roles in gene regulation and tumor progression. Experimental assays remain costly and incomplete, underscoring the need for computational approaches. To address this, a deep learning framework termed DeepECC has been established to overcome the challenges posed by eccDNA heterogeneity and its complex biogenesis. Through a two-stage training strategy, DeepECC models the local sequence context flanking both the start and end breakpoints, thereby capturing mechanistically informative features that are often overlooked when analyses focus solely on eccDNA body sequences. Applied to multi-species (human, mouse, gallus) datasets, DeepECC robustly captures conserved breakpoint features, with a marked preference for GC-rich and transcriptionally active regions. Genome-wide scanning reveals non-uniform distributions of human cancer eccDNAs enriched in enhancers, expression quantitative trait loci, and CTCF sites, suggesting regulatory functions in tumor progression. Motif analysis further implicates ribosomal activity, translational regulation, and DNA damage response. Furthermore, genome-wide eccDNA predictions are integrated into the UCSC Genome Browser, enabling convenient querying and visualization of cancer-related eccDNAs associated with specific genes or genomic regions, facilitating functional interpretation for experimental research. Collectively, DeepECC provides a generalizable framework for systematic eccDNA discovery and insights into their functional significance in cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.